Form 4: Travere Therapeutics Director Suzanne Bruhn Acquires Shares and Stock Options

Director Suzanne Bruhn acquired 6,500 shares of common stock and 19,500 stock options in Travere Therapeutics on May 15, 2025, under the company's equity incentive plan.

Summary

• On May 15, 2025, Suzanne Louise Bruhn, a director of Travere Therapeutics, acquired 6,500 shares of common stock and 19,500 stock options.
• The acquisition of common stock was an automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program.
• The price of the acquired common stock was $0.
• The stock options have an exercise price of $21.15 and expire on May 15, 2035.
• The equity award vests over a one-year period.
• Following the transaction, Ms. Bruhn directly owns 28,750 shares of common stock and 19,500 stock options.

Sentiment

Score: 7

Explanation: The document reflects a routine equity grant to a director, indicating confidence in the company's future. The vesting period aligns the director's interests with the company's long-term performance.

Positives

• The acquisition of shares and stock options by a director signals confidence in the company's future.
• The equity award vests over a one-year period, incentivizing the director to contribute to the company's success.

Future Outlook

The equity award vests over a one-year period, suggesting continued involvement and alignment of interests between the director and the company.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment with company performance.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding director compensation and ownership.
• The vesting schedule incentivizes the director to contribute to the company's success, potentially benefiting all stakeholders.

Key Dates

Keywords

Travere Therapeutics, Director, Suzanne Bruhn, Stock Options, Equity Incentive Plan, Beneficial Ownership, Form 4, TVTX